Yangyang Zhou

2.4k total citations · 1 hit paper
55 papers, 1.2k citations indexed

About

Yangyang Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yangyang Zhou has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yangyang Zhou's work include Gastric Cancer Management and Outcomes (6 papers), RNA modifications and cancer (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Yangyang Zhou is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), RNA modifications and cancer (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Yangyang Zhou collaborates with scholars based in China, United States and Netherlands. Yangyang Zhou's co-authors include Hong Su, Haojie Jin, Siying Wang, Wenxin Qin, Yuanyuan Lv, Cun Wang, Xiaojing Du, Chen Yang, Zhuoan Cheng and Chunlai Lu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yangyang Zhou

48 papers receiving 1.2k citations

Hit Papers

circNDUFB2 inhibits non-small cell lung cancer progressio... 2021 2026 2022 2024 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
    2021 416 citations Botai Li, Lili Zhu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangyang Zhou China 19 738 504 220 201 99 55 1.2k
Meng Gu China 22 662 0.9× 387 0.8× 235 1.1× 295 1.5× 86 0.9× 94 1.2k
Kai Zhou China 20 590 0.8× 378 0.8× 263 1.2× 133 0.7× 141 1.4× 74 1.2k
Yuki Yoshikawa Japan 20 606 0.8× 416 0.8× 186 0.8× 138 0.7× 112 1.1× 69 1.0k
Huan Xu China 22 638 0.9× 376 0.7× 333 1.5× 240 1.2× 82 0.8× 56 1.3k
Xiang Gao China 19 498 0.7× 240 0.5× 218 1.0× 190 0.9× 137 1.4× 71 1.1k
Zhikang Chen China 19 690 0.9× 378 0.8× 245 1.1× 129 0.6× 102 1.0× 64 1.1k
Isabelle Ader France 26 930 1.3× 308 0.6× 216 1.0× 98 0.5× 67 0.7× 43 1.5k
Yanqin Sun China 19 776 1.1× 604 1.2× 219 1.0× 174 0.9× 57 0.6× 65 1.2k

Countries citing papers authored by Yangyang Zhou

Since Specialization
Citations

This map shows the geographic impact of Yangyang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Zhou more than expected).

Fields of papers citing papers by Yangyang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Zhou. The network helps show where Yangyang Zhou may publish in the future.

Co-authorship network of co-authors of Yangyang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Zhou. A scholar is included among the top collaborators of Yangyang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Zhou. Yangyang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jianyong, Ruqi Tang, Haitao Luo, et al.. (2025). Data‐Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness. CNS Neuroscience & Therapeutics. 31(4). e70408–e70408.
2.
Jing, Ling, Siying Wang, Chenhe Yi, et al.. (2025). PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18. Hepatology Communications. 9(4). 1 indexed citations
3.
Mao, Yue, Yangyang Zhou, Yue Zhao, et al.. (2025). Oridonin combined with cisplatin synergistically induces apoptosis by activating the NOXA-BCL2 axis in esophageal squamous cell carcinoma. Biochemical Pharmacology. 237. 116953–116953. 1 indexed citations
4.
Zhang, Tiantian, et al.. (2025). Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer. Scientific Reports. 15(1). 12175–12175. 3 indexed citations
5.
Zhou, Yangyang, Yi Xu, Jingjing Xing, et al.. (2025). Integrated single-cell RNA-seq analysis reveals that EZH2 regulates the MIF-CD74 axis to modulate T cell activation and exhaustion in hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 1040–1040.
6.
Geng, Haigang, Chen Huang, Lei Xu, et al.. (2024). Targeting cellular senescence as a therapeutic vulnerability in gastric cancer. Life Sciences. 346. 122631–122631. 4 indexed citations
7.
8.
Zhang, Chun‐Dong, Quanquan Sun, Qianping Chen, et al.. (2023). Unraveling Colorectal Cancer and Pan-cancer Immune Heterogeneity and Synthetic Therapy Response Using Cuproptosis and Hypoxia Regulators by Multi-omic Analysis and Experimental Validation. International Journal of Biological Sciences. 19(11). 3526–3543. 8 indexed citations
9.
Yang, Yan, Junjun Wang, Hanqi Yang, et al.. (2023). Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer. Frontiers in Oncology. 13. 1185240–1185240.
10.
Zhou, Yangyang, et al.. (2023). Roles of TSP1-CD47 signaling pathway in senescence of endothelial cells: cell cycle, inflammation and metabolism. Molecular Biology Reports. 50(5). 4579–4585. 9 indexed citations
11.
Xing, Yingqi, et al.. (2021). Carotid intraplaque neovascularisation as a predictive factor for future vascular events in patients with mild and moderate carotid stenosis: an observational prospective study. Therapeutic Advances in Neurological Disorders. 14. 4203305080–4203305080. 17 indexed citations
12.
Li, Botai, Lili Zhu, Chunlai Lu, et al.. (2021). circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nature Communications. 12(1). 295–295. 416 indexed citations breakdown →
13.
Yu, Min, et al.. (2019). Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Zhou, Yangyang, Liping Chen, Yi Zhang, et al.. (2019). Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer. Molecular Medicine. 25(1). 47–47. 34 indexed citations
15.
Chen, Liping, Jiabing Wang, Yangyang Zhou, et al.. (2018). Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition. European Journal of Medicinal Chemistry. 151. 508–519. 34 indexed citations
16.
17.
Wu, Jianzhang, Xiaojing Du, Wulan Li, et al.. (2017). A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration. APOPTOSIS. 22(6). 852–864. 10 indexed citations
18.
Zhou, Yangyang, et al.. (2014). Association of thyroid carcinoma with pregnancy: A meta-analysis. Molecular and Clinical Oncology. 3(2). 341–346. 20 indexed citations
19.
Zhou, Yangyang, Yingqi Xing, Yan Li, et al.. (2013). An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity. BMC Medical Imaging. 13(1). 13–13. 31 indexed citations
20.
Song, Jian, et al.. (2013). Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(3). 1615–1621. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng Gu Breakdown of academic impact, for papers by Kai Zhou Breakdown of academic impact, for papers by Yuki Yoshikawa Breakdown of academic impact, for papers by Huan Xu Breakdown of academic impact, for papers by Xiang Gao Breakdown of academic impact, for papers by Zhikang Chen Breakdown of academic impact, for papers by Isabelle Ader Breakdown of academic impact, for papers by Yanqin Sun
Rankless by CCL
2026